Barclays Maintains Overweight on Hinge Health, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 78.1%

Neg 0% Neu 0% Pos 78.1%

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $100 to $110.